Alan S Gamis

16PUBLICATIONS
82CO-AUTHORS
Gene and molecular therapyMedical infection agents (incl. prions)HaematologyHaematological tumoursNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 05, 2026
Combining menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia.

|Oct 22, 2025
Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease.

Jason N Berman, Anupam Verma, Shelton Viola

|Apr 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Benjamin J Huang, Lauren K Meyer, Todd A Alonzo

|Apr 15, 2024
Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Romy E van Weelderen, Christine J Harrison, Kim Klein

|Feb 02, 2024
Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.

Oussama Abla, Rhonda E Ries, Tim Triche

|Jan 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.

Katherine Tarlock, Robert B Gerbing, Rhonda E Ries

Pageof 3

Frequent Collaborators

10 joint publications

Richard Aplenc

5 joint publications

Edward Anders Kolb

4 joint publications

Benjamin J Huang

4 joint publications

Katherine Tarlock